Isocombretastatins a versus combretastatins a: the forgotten isoCA-4 isomer as a highly promising cytotoxic and antitubulin agent.

Archive ouverte

Messaoudi, Samir | Tréguier, Bret | Hamze, Abdallah | Provot, Olivier | Peyrat, Jean-François | de Losada, Jordi Rodrigo | Liu, Jian-Miao | Bignon, Jérôme | Wdzieczak-Bakala, Joanna | Thoret, Sylviane | Dubois, Joëlle | Brion, Jean-Daniel | Alami, Mouâd

Edité par CCSD ; American Chemical Society -

International audience. Herein is reported a convergent synthesis of isocombretastatins A, a novel class of potent antitubulin agents. These compounds having a 1,1-diarylethylene scaffold constitute the simplest isomers of natural Z-combretastatins A that are easy to synthesize without need to control the Z-olefin geometry. The discovery of isoCA-4 with biological activities comparable to that of CA-4 represents a major progress in this field.

Consulter en ligne

Suggestions

Du même auteur

Synthesis and antitumor activity of benzils related to combretastatin A-4

Archive ouverte | Mousset, Céline | CCSD

International audience. A series of benzil derivatives related to combretastatin A-4 (CA-4) has been synthesized by oxidation of diarylalkynes promoted by PdI2 in DMSO. Using this new protocol, 14 benzils were prepa...

Synthesis of anti-microtubule biaryls and preliminary evaluation as vascular-disrupting agents.

Archive ouverte | Joncour, Agnès | CCSD

International audience. A series of new dibenzoxepines were synthesized in a straightforward and efficient manner through diastereoselective biaryl Suzuki-Miyaura coupling and Br?ed-acid-mediated cyclodehydration as...

1,1-Diheterocyclic Ethylenes Derived from Quinaldine and Carbazole as New Tubulin-Polymerization Inhibitors: Synthesis, Metabolism, and Biological Evaluation

Archive ouverte | Naret, Timothée | CCSD

International audience. We report the synthesis and metabolic and biological evaluation of a series of 17 novel heterocyclic derivatives of isocombretastatin-A4 (iso-CA-4) and their structure-activity relationships....

Chargement des enrichissements...